Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity.

Subjects

Subjects :

*TUMOR treatment
*CONSENSUS (Social sciences)
*MEDICAL research
*MYCOSES
*TERMS & phrases

Details

Language :

English

ISSN :

10584838

Volume :

71

Issue :

12

Database :

Academic Search Index

Journal :

Clinical Infectious Diseases

Publication Type :

Academic Journal

Accession number :

148275437

Full Text :

https://doi.org/10.1093/cid/ciaa323